These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30029202)

  • 1. Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid.
    Beauvais D; Goossens JF; Boyle E; Allal B; Lafont T; Chatelut E; Herbaux C; Morschhauser F; Genay S; Odou P; Danel C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():158-166. PubMed ID: 30029202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
    Veeraraghavan S; Viswanadha S; Thappali S; Govindarajulu B; Vakkalanka S; Rangasamy M
    J Pharm Biomed Anal; 2015 Mar; 107():151-8. PubMed ID: 25594893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry.
    Guo YJ; Du TT; Yang YL; Zhao Y; Chen XL; Ma H; Sun LN; Wang YQ
    Ther Drug Monit; 2024 Oct; 46(5):634-641. PubMed ID: 38531816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC-ESI-MS/MS: validation and application to pharmacokinetic studies of a novel ibrutinib nanocrystalline.
    Sun S; Cheng D; Kong S; Li X; Li T; Yu Q; Wang L
    Biomed Chromatogr; 2020 Jan; 34(1):e4703. PubMed ID: 31629393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.
    Sun LN; Zhao Y; Qian ZY; Chen XL; Ma H; Guo YJ; Shen H; Wang YQ
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies.
    Rood JJM; van Hoppe S; Schinkel AH; Schellens JHM; Beijnen JH; Sparidans RW
    J Pharm Biomed Anal; 2016 Jan; 118():123-131. PubMed ID: 26540627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput salting-out assisted liquid-liquid extraction using a 3D printed device and its application in the quantification of ibrutinib and its metabolite PCI-45227 in human serum.
    Écsiová D; Šimkovič M; Uher M; Hroch M
    J Pharm Biomed Anal; 2022 Sep; 219():114923. PubMed ID: 35830774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS.
    Qiu X; Lin Q; Ning Z; Qian X; Li P; Ye L; Xie S
    J Pharm Biomed Anal; 2019 Mar; 166():66-70. PubMed ID: 30612075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of evobrutinib and its metabolite evobrutinib-diol in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
    Yang J; Yu H; Tang Q
    Biomed Chromatogr; 2019 Sep; 33(9):e4575. PubMed ID: 31069837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry.
    Rood JJM; Dormans PJA; van Haren MJ; Schellens JHM; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1090():14-21. PubMed ID: 29778873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of naringenin on the pharmacokinetics of ibrutinib in rat: A drug-drug interaction study.
    Liu J; Liu H; Zeng Q
    Biomed Chromatogr; 2019 May; 33(5):e4507. PubMed ID: 30754071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous measurement of acalabrutinib, ibrutinib, and their metabolites in beagle dog plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Jiang Z; Shi L; Zhang Y; Lin G; Wang Y
    J Pharm Biomed Anal; 2020 Nov; 191():113613. PubMed ID: 32971496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
    Liu C; Lu Y; Sun H; Yang J; Liu Y; Lai X; Gong Y; Liu X; Li Y; Zhang Y; Chen X; Zhong D
    J Pharm Biomed Anal; 2018 Feb; 149():394-402. PubMed ID: 29154109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An UHPLC-MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction.
    Lin PP; Chen WL; Yuan F; Sheng L; Wu YJ; Zhang WW; Li GQ; Xu HR; Li XN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():82-91. PubMed ID: 29102244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an UHPLC-ESI-QTOF-MS method for quantification of the highly hydrophilic amyloid-β oligomer eliminating all-D-enantiomeric peptide RD2 in mouse plasma.
    Hupert M; Elfgen A; Schartmann E; Schemmert S; Buscher B; Kutzsche J; Willbold D; Santiago-Schübel B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():123-129. PubMed ID: 29248770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS/MS.
    Eliassen E; Kristoffersen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():72-80. PubMed ID: 25264915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple determination of plasma ibrutinib concentration using high-performance liquid chromatography.
    Yasu T; Momo K; Yasui H; Kuroda S
    Biomed Chromatogr; 2019 Mar; 33(3):e4435. PubMed ID: 30421802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of tandospirone and its active metabolite, 1-[2-pyrimidyl]-piperazine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
    Hu W; Jia M; He S; Xie H; Jiang X; Wang L
    Biomed Chromatogr; 2019 Jul; 33(7):e4525. PubMed ID: 30822365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.
    Gradinaru J; Vullioud A; Eap CB; Ansermot N
    J Pharm Biomed Anal; 2014 Jan; 88():36-44. PubMed ID: 24036032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a hydrophilic interaction ultra-high-performance liquid chromatography-tandem mass spectrometry method for rapid simultaneous determination of 19 free amino acids in rat plasma and urine.
    Wen Y; Yuan X; Qin F; Zhao L; Xiong Z
    Biomed Chromatogr; 2019 Jan; 33(1):e4387. PubMed ID: 30238479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.